Edge Therapeutics to Present at the 26th Annual Credit Suisse Healthcare Conference
06 nov. 2017 07h00 HE
|
Edge Therapeutics, Inc.
BERKELEY HEIGHTS, N.J., Nov. 06, 2017 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq:EDGE), a clinical-stage biotechnology company developing novel hospital-based therapies for the management...
Edge Therapeutics Reports Third Quarter 2017 Financial Results
01 nov. 2017 07h00 HE
|
Edge Therapeutics, Inc.
BERKELEY HEIGHTS, N.J., Nov. 01, 2017 (GLOBE NEWSWIRE) -- Edge Therapeutics®, Inc. (Nasdaq:EDGE), a clinical-stage biotechnology company developing novel hospital-based therapies for the management...
Edge Therapeutics Announces Third Quarter Financial Results Conference Call on November 1, 2017
18 oct. 2017 07h00 HE
|
Edge Therapeutics, Inc.
BERKELEY HEIGHTS, N.J., Oct. 18, 2017 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq:EDGE), a clinical-stage biotechnology company developing novel hospital-based therapies in the management of...
Edge Therapeutics to Present at the Neurocritical Care Society 15th Annual Meeting
06 oct. 2017 07h00 HE
|
Edge Therapeutics, Inc.
BERKELEY HEIGHTS, N.J., Oct. 06, 2017 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq:EDGE), a clinical-stage biotechnology company developing novel hospital-based therapies for the management...
Edge Therapeutics to Present at Upcoming Investor Conferences
20 sept. 2017 07h00 HE
|
Edge Therapeutics, Inc.
BERKELEY HEIGHTS, N.J., Sept. 20, 2017 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq:EDGE), a clinical-stage biotechnology company developing novel hospital-based therapies for the management...
Edge Therapeutics Appoints Rosemary A. Crane, Pharmaceutical Industry Leader, to its Board of Directors
19 sept. 2017 07h00 HE
|
Edge Therapeutics, Inc.
BERKELEY HEIGHTS, N.J., Sept. 19, 2017 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq:EDGE), a clinical-stage biotechnology company developing novel hospital-based therapies for the management...
Edge Therapeutics Reports Second Quarter 2017 Financial Results and Continued Operational Progress
01 août 2017 06h30 HE
|
Edge Therapeutics, Inc.
BERKELEY HEIGHTS, N.J., Aug. 01, 2017 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq:EDGE), a clinical-stage biotechnology company developing novel hospital-based therapies for the management...
Edge Therapeutics Announces Second Quarter Financial Results Conference Call on August 1, 2017
18 juil. 2017 07h00 HE
|
Edge Therapeutics, Inc.
BERKELEY HEIGHTS, N.J., July 18, 2017 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq:EDGE), a clinical-stage biotechnology company developing novel hospital-based therapies in the management of...
Edge Therapeutics Announces Commercial Supply Agreement for EG-1962 with Oakwood Laboratories
06 juil. 2017 06h30 HE
|
Edge Therapeutics, Inc.
BERKELEY HEIGHTS, N.J., July 06, 2017 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq:EDGE) today announced that it has entered into a supply agreement and an amended and restated development...
Edge Therapeutics to Participate in the JMP Securities Life Science Conference
15 juin 2017 07h00 HE
|
Edge Therapeutics, Inc.
BERKELEY HEIGHTS, N.J., June 15, 2017 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq:EDGE), a clinical-stage biotechnology company developing novel hospital-based therapies in the management of...